Clinical Registries Need Streamlining To Reap Benefits, Mussallem Tells Congress :: “The Gray Sheet” :: Pharma & Medtech Business Intelligence

Clinical Registries Need Streamlining To Reap Benefits, Mussallem Tells Congress :: “The Gray Sheet” :: Pharma & Medtech Business Intelligence: "Clinical registries can yield useful information on patient outcomes that can support approval, reimbursement and care decisions but the benefits of registries need to be balanced against their costs, Edwards Lifesciences CEO Michael Mussalem told a House Energy and Commerce subcommittee July 22."